Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Remix Therapeutics
Remix Therapeutics
Eye & ENT Hospital of Fudan University
VM Oncology, LLC
Rgenta Therapeutics Inc
Mersana Therapeutics
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Novelty Nobility, Inc.
Dana-Farber Cancer Institute
HitGen Inc.
Heidelberg University
Qingdao Central Hospital